Contains fulltext : 80509.pdf (publisher's version ) (Closed access)Episomes with the NUP214-ABL1 fusion gene have been observed in 6% of T-ALL. In this multicentric study we collected 27 cases of NUP214-ABL1-positive T-ALL. Median age was 15 years with male predominance. Outcome was poor in 12 patients. An associated abnormality involving TLX1 or TLX3 was found in all investigated cases. Fluorescent in situ hybridization revealed a heterogeneous pattern of NUP214-ABL1 amplification. Multiple episomes carrying the fusion were detected in 24 patients. Episomes were observed in a significant number of nuclei in 18 cases, but in only 1-5% of nuclei in 6. In addition, intrachromosomal amplification (small hsr) was identified e...
Background: Variations in disease presentation and outcome of leukemia treatment has been associated...
Objective: Children suffer from ALL (Acute Lymphoblastic Leukemia) a malignant tumour most commonly ...
The t(1;19)(q23;p13) chromosomal translocation is observed cytogenetically in 25 % of children with ...
Episomes with the NUP214-ABL1 fusion gene have been observed in 6% of T-ALL. In this multicentric st...
Episomes with the NUP214-ABL1 fusion gene have been observed in 6% of T-ALL. In this multicentric st...
In T-cell acute lymphoblastic leukemia (T-ALL), transcription factors are known to be deregulated by...
T-cell acute lymphoblastic leukemia (T-ALL) is the result of multiple oncogenic insults of thymocyte...
Abstract Background ABL1 gene translocations can be seen in precursor T-acute lymphoblastic leukemia...
Background and Objectives: Recent data have highlighted an involvement of ABL1 in T-cell acute lymph...
Over the last decade, genetic characterization of T-cell acute lymphoblastic leukemia (T-ALL) has le...
TEL/AML1 gene fusion that results from a cryptic t(12;21) is the most common genetic aberration in c...
Contains fulltext : 169868.pdf (Publisher’s version ) (Open Access)Approximately 1...
Background and Objectives Recent data have highlighted an involvement of ABL1 in T-cell acute lympho...
The NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia (T-ALL) has recently been identif...
BCR-ABL1 positive acute lymphoblastic leukemia (ALL) is an aggressive subtype of ALL that commonly a...
Background: Variations in disease presentation and outcome of leukemia treatment has been associated...
Objective: Children suffer from ALL (Acute Lymphoblastic Leukemia) a malignant tumour most commonly ...
The t(1;19)(q23;p13) chromosomal translocation is observed cytogenetically in 25 % of children with ...
Episomes with the NUP214-ABL1 fusion gene have been observed in 6% of T-ALL. In this multicentric st...
Episomes with the NUP214-ABL1 fusion gene have been observed in 6% of T-ALL. In this multicentric st...
In T-cell acute lymphoblastic leukemia (T-ALL), transcription factors are known to be deregulated by...
T-cell acute lymphoblastic leukemia (T-ALL) is the result of multiple oncogenic insults of thymocyte...
Abstract Background ABL1 gene translocations can be seen in precursor T-acute lymphoblastic leukemia...
Background and Objectives: Recent data have highlighted an involvement of ABL1 in T-cell acute lymph...
Over the last decade, genetic characterization of T-cell acute lymphoblastic leukemia (T-ALL) has le...
TEL/AML1 gene fusion that results from a cryptic t(12;21) is the most common genetic aberration in c...
Contains fulltext : 169868.pdf (Publisher’s version ) (Open Access)Approximately 1...
Background and Objectives Recent data have highlighted an involvement of ABL1 in T-cell acute lympho...
The NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia (T-ALL) has recently been identif...
BCR-ABL1 positive acute lymphoblastic leukemia (ALL) is an aggressive subtype of ALL that commonly a...
Background: Variations in disease presentation and outcome of leukemia treatment has been associated...
Objective: Children suffer from ALL (Acute Lymphoblastic Leukemia) a malignant tumour most commonly ...
The t(1;19)(q23;p13) chromosomal translocation is observed cytogenetically in 25 % of children with ...